Can a CT Scan Show Kidney Disease?

CT scans can reveal a wide range of kidney problems, from stones and tumors to infections and structural abnormalities, making them one of the most versatile imaging tools in kidney care. They are not, however, a single test for “kidney disease” in the way a blood test for creatinine is. What a CT scan shows depends heavily on the type of kidney problem involved, whether contrast dye is used, and the specific scanning protocol. For conditions like kidney stones or suspicious masses, CT is the gold standard. For others, like early chronic kidney disease detected by declining lab values, a CT scan may appear largely normal.

What a CT Scan Actually Shows

A CT scan produces detailed cross-sectional images of the kidneys, giving doctors a clear look at their size, shape, internal structure, and surrounding tissue. It can pick up solid masses, fluid-filled cysts, calcifications, blockages in the urinary tract, swelling, and abnormal blood flow patterns when contrast dye is injected. The level of detail is high enough that radiologists can often distinguish between a harmless cyst and a potentially cancerous growth based on how the tissue responds to contrast material.

There are several ways to perform a kidney CT. A non-contrast scan skips the dye entirely and is the go-to choice for evaluating kidney stones. A contrast-enhanced scan involves injecting iodine-based dye into a vein, which highlights blood flow and tissue perfusion, making tumors, infections, and vascular problems much easier to spot. Multiphase CT protocols capture images at different time points after the dye injection, which helps characterize masses based on how quickly and intensely they absorb the contrast material.

Kidney Stones

For suspected kidney stones, non-contrast CT of the abdomen and pelvis is the most accurate diagnostic tool available.¹ It can detect stones as small as one or two millimeters regardless of their mineral composition, which is something X-rays and ultrasound often miss. The scan also reveals whether a stone is causing a blockage by showing signs of swelling in the kidney or a dilated ureter upstream from the stone.

That said, rare exceptions exist. A case report documented a renal stone that was undetectable on CT, a reminder that while the technology catches the vast majority of stones, no test is perfect.² Certain stone compositions, particularly some drug-related stones, can have densities close to surrounding tissue and slip past the scan. These situations are uncommon enough that CT remains the first-line choice, but they explain why doctors sometimes pursue additional testing when symptoms persist despite a clean scan.

Compared with ultrasound, CT consistently detects more stones and measures them more accurately. One study found that ultrasound had a sensitivity of roughly 77% for stones visible on CT, and it tended to overestimate stone size by an average of about 2 mm.³ Another study put ultrasound sensitivity even lower, between 32% and 57% depending on which kidney and which radiologist was reading the images.⁴ In children, ultrasound performs somewhat better but still misses about a third of stones, though most of the missed stones are very small.⁵

Kidney Masses and Cancer

CT is the primary tool for detecting and characterizing kidney masses. When a radiologist identifies a solid mass that takes up contrast dye, it raises suspicion for renal cell carcinoma, the most common type of kidney cancer. Multiphase scanning improves the ability to spot small masses. Research has shown that images captured during the nephrographic phase, taken about 100 seconds after contrast injection when the entire kidney tissue is uniformly enhanced, detect significantly more small masses under 3 cm than earlier-phase images alone.⁶

The traditional four-phase kidney CT protocol includes images before contrast, during the arterial phase, during the nephrographic phase, and during a later excretory phase. However, a study of patients with renal lesions larger than 10 mm found that a three-phase protocol without the nephrographic phase had similar diagnostic ability to the full four-phase scan.⁷ This matters for patients because fewer scan phases mean less radiation. In practice, the specific protocol your radiologist uses will depend on what they are looking for and what has already been seen on prior imaging.

When it comes to staging a confirmed kidney cancer, CT performs reasonably well but has known limitations. One study comparing CT and MRI found that both modalities detected all surgically confirmed kidney tumors, but each correctly staged only about two-thirds of renal cell carcinomas. The challenge lies in determining whether a cancer has invaded nearby structures or the renal vein, which can be difficult to see on any imaging modality.

Cystic Lesions

Simple kidney cysts are extremely common and almost always harmless. CT picks them up easily, and they show up as smooth, fluid-filled pockets with thin walls and no internal complexity. The trickier question is what to do when a cyst is not so simple. Complex cysts with thick walls, internal divisions, calcifications, or solid components can occasionally harbor cancer.

For more than 30 years, doctors have used the Bosniak classification system to sort cystic kidney lesions by their cancer risk based on CT appearance.⁸ A systematic review and meta-analysis confirmed that the Bosniak system is an accurate way to stratify malignancy risk in cystic kidney lesions.⁹ Category I and II cysts are considered benign and need no follow-up. Higher categories require either surveillance imaging or surgical removal, depending on how concerning the features look.

Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease is a genetic condition in which hundreds of cysts gradually enlarge the kidneys and compromise function over decades. Tracking total kidney volume is one of the main ways doctors monitor how fast the disease is progressing, and imaging is essential for that measurement.¹⁰

MRI has traditionally been the reference standard for kidney volume measurements, but CT can produce comparably accurate results. A study evaluating different measurement methods found that even ultra-low-dose CT protocols generated kidney volume measurements with excellent correlation to MRI, with a correlation coefficient above 0.98.¹¹ Separate research found that reproducibility for volume measurements was actually higher on CT than MRI across several measurement methods.¹² For patients who cannot have MRI or who need repeated monitoring, CT is a reliable alternative.

Kidney Infections

Most uncomplicated urinary tract infections do not need imaging. But when a kidney infection, or pyelonephritis, does not respond to antibiotics within a couple of days, CT becomes the preferred way to assess what is going on. It is considered the imaging modality of choice for evaluating the severity of pyelonephritis, outperforming ultrasound in sensitivity and specificity.¹³ Contrast-enhanced CT can show areas of the kidney where blood flow is reduced due to inflammation, highlight abscesses that may need drainage, and identify gas within the kidney tissue, a dangerous condition called emphysematous pyelonephritis.

Emphysematous pyelonephritis is a life-threatening infection that occurs most often in people with diabetes or urinary obstruction. Early CT imaging can make the difference between catching it in time for conservative treatment and missing it until the kidney needs to be surgically removed.¹⁴ CT is also the preferred tool over conventional X-rays and ultrasound for assessing this condition.¹⁵

Renal Artery Stenosis

Narrowing of the arteries that supply the kidneys, called renal artery stenosis, can cause hard-to-control high blood pressure and progressive kidney damage. CT angiography is one of the main non-invasive ways to check for this condition. One study found that CT angiography had a sensitivity of 94% and specificity of 93% for detecting renal artery stenosis, with a negative predictive value of 99%, meaning a clean CT angiogram strongly rules out significant narrowing.¹⁶

However, the evidence is not uniformly glowing. A broader analysis that pooled results from multiple studies found a combined sensitivity of only 64% and specificity of 92% for CT angiography in diagnosing renal artery stenosis, leading the authors to conclude that it was not reproducible or sensitive enough to reliably rule out the condition in hypertensive patients.¹⁷ The discrepancy likely reflects differences in patient populations, scanning technology, and how stenosis was defined across studies. In practice, CT angiography is useful as a screening tool, but digital subtraction angiography, which threads a catheter directly into the blood vessels, remains the definitive test when the diagnosis is uncertain.

Where CT Falls Short

The phrase “kidney disease” most often refers, in everyday conversation, to chronic kidney disease, the gradual loss of kidney function measured by blood tests showing rising creatinine and falling filtration rates. This is where CT disappoints. In early and moderate chronic kidney disease, the kidneys can look structurally normal on a scan. You can have significantly impaired function with kidneys that appear perfectly fine on imaging, because the damage is happening at a microscopic level, in the tiny filtering units and surrounding tissue, that standard CT resolution cannot capture.

Research using advanced CT angiography techniques has found that patients with chronic kidney disease and fibrosis had measurably reduced renal blood volume in the kidney cortex compared with patients without the condition, and that arteries within the kidney were narrower and less branched. But these findings required specialized post-processing of the images and are not part of a routine clinical CT report. For the typical patient, chronic kidney disease is diagnosed and monitored through blood and urine tests, not imaging.

Acute kidney injury is another condition where CT has limited value. The utility of contrast-enhanced CT for evaluating acute kidney injury is constrained because the contrast dye itself carries at least a theoretical risk of worsening kidney function.¹⁸ CT may be performed to look for a specific structural cause of the injury, like an obstruction, but it cannot show the cellular damage that defines the condition.

Is Contrast Dye Safe for Damaged Kidneys?

One of the most persistent concerns about CT scans involves the iodine-based contrast dye used in enhanced studies. For decades, the assumption was that this dye posed a serious risk of further kidney injury, especially in patients who already had reduced kidney function. Recent large-scale research has substantially softened that worry.

A meta-analysis of 21 propensity-matched studies found that the overall risk of acute kidney injury was similar between patients who received contrast and those who did not, with an odds ratio of 0.97, regardless of baseline kidney function or underlying disease.¹⁹ In other words, the people who got dye were no more likely to develop kidney injury than comparable patients who had unenhanced scans. The same analysis did identify hypertension and very low kidney function as factors linked to higher risk, which is why extra precaution is still warranted in those patients.

A large propensity-matched study came to a similar conclusion. Across different levels of kidney function, the rate of acute kidney injury was not significantly different between contrast and non-contrast groups, even in the sickest patients.²⁰ Research in patients specifically diagnosed with chronic kidney disease found that rates of acute kidney injury, emergency dialysis, and death were not significantly higher in those who received contrast compared to those who did not.²¹

This does not mean contrast is given carelessly. When patients have severely reduced kidney function, many centers still use intravenous hydration before and after the scan to protect the kidneys. A rapid outpatient hydration protocol was associated with a 95% reduction in imaging appointment postponements without complications from fluid overload.²² The optimal hydration strategy for patients with very low kidney function, whether intravenous or oral fluid, has not been firmly established, and a clinical trial is underway to compare the two approaches.²³ The practical takeaway: if your doctor recommends a contrast-enhanced CT and you have reduced kidney function, the risk is much lower than previously thought, and the scan should not be reflexively avoided when the information it provides is clinically important.

Incidental Kidney Findings

One consequence of CT’s sensitivity is that scans done for entirely unrelated reasons frequently turn up unexpected kidney findings. A study of patients who had non-contrast CT for other indications found that roughly 14% had at least one renal mass.²⁴ The vast majority of these, about 87%, were classified as benign based on their imaging characteristics. Among the indeterminate ones that were followed over an average of more than four years, only a small fraction turned out to be renal cell carcinoma.

The American College of Radiology has published guidelines to help radiologists manage these incidental kidney masses, providing flowcharts based on imaging features that indicate when additional imaging, surveillance, or referral is needed.²⁵ The growing use of abdominal CT for various conditions has led to an increasing number of these incidental kidney findings, making standardized management more important than ever.²⁶ If you undergo an abdominal CT scan for, say, appendicitis symptoms and the report mentions a small kidney cyst, the finding is almost certainly inconsequential. But the formal recommendation system exists to ensure that the rare concerning lesion is not ignored.

Lowering the Radiation Dose

Radiation exposure is a reasonable concern, especially for people who need repeated scans over time, such as those being monitored for kidney stones or polycystic kidney disease. The good news is that low-dose and ultra-low-dose CT protocols have matured considerably. A systematic review found that ultra-low-dose and low-dose CT protocols for the kidneys, ureters, and bladder maintained a sensitivity of 90 to 100% and specificity of 86 to 100% across studies.²⁷ For stone detection in particular, these protocols deliver a fraction of the radiation of a standard scan while still catching the overwhelming majority of clinically significant stones.

Artificial intelligence is also entering the picture. Researchers have developed deep-learning models trained on CT kidney images that can automatically segment the kidney and classify findings into normal, cyst, stone, and tumor categories with accuracy above 99% in cross-validation testing.²⁸ These tools are still in development and have not replaced human radiologists, but they point toward a future where CT kidney analysis becomes faster and potentially more consistent, particularly in settings with fewer specialized radiologists available.